Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.04. | hVIVO PLC - Annual Report & Notice of AGM | - | RNS | ||
09.04. | hVIVO swings to profit and commences annual dividends as outlook rosy | 1 | Alliance News | ||
09.04. | Hvivo unveils record results and bullish growth targets | 1 | Sharecast | ||
09.04. | hVIVO reports higher profits and revenues for 2023 | 3 | RTE.ie | ||
09.04. | hVIVO PLC - Final results | 1 | RNS | ||
27.03. | hVIVO PLC - Notice of Results | - | RNS | ||
22.03. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
14.03. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
16.02. | hVIVO directors sell 29 million shares, Greencore director buys on positive forecast | Director Deals | 6 | Shares | ||
15.02. | hVIVO PLC - Long Term Incentive Plan / PDMR Notification | 1 | RNS | ||
14.02. | IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares | 2 | Alliance News | ||
14.02. | hVIVO PLC - Result of Secondary Placing | - | RNS | ||
14.02. | IN BRIEF: hVIVO directors to sell total of 14 million shares | 2 | Alliance News | ||
14.02. | hVIVO PLC - Proposed Secondary Placing of Ordinary Shares | - | RNS | ||
02.02. | hVIVO PLC - Holding(s) in Company | 2 | RNS | ||
30.01. | hVIVO shares up after "record year" across all metrics | 1 | Alliance News | ||
30.01. | Life sciences firm hVIVO has record year as Canary Wharf site set for completion | 1 | City A.M. | ||
30.01. | hVIVO PLC - Trading update | - | RNS | ||
08.01. | hVIVO PLC - Broker change | 1 | RNS | ||
02.01. | hVIVO inks GBP6.3 million deal to test common cold treatment | 1 | Alliance News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 99,00 | -1,39 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
INTUITIVE SURGICAL | 348,20 | -0,64 % | Quartalszahlen: China sei Dank: Intuitive Surgical übertrifft Erwartungen, Aktie steigt! | © Foto: Frank Molter - picture allianceDie Aktie des Herstellers von Medizinrobotern Intuitive Surgical ist nach guten Quartalszahlen gefragt und steigt.Erholung in China ließ lange auf sich warten... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,592 | +5,15 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
BAXTER | 36,960 | -3,39 % | Exergen Corporation: Exergen verklagt Baxter International, um sein Recht auf Veröffentlichung von Daten zur Genauigkeit von Oralthermometern zu verteidigen | Letzte Woche reichte die Exergen Corporation beim United States District Court für den District of Massachusetts eine Klage gegen Baxter International Inc. ein. Wie in der Klageschrift dargelegt,... ► Artikel lesen | |
SPINEWAY | 0,760 | -16,67 % | SPINEWAY: Growth of 28% of 2024 first quarter revenue | Press release Ecully, April 16, 2024 - 8 p.m. First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter In thousands of euros20242023Change 2023/2022Q1 revenue3... ► Artikel lesen | |
CO-DIAGNOSTICS | 1,060 | -1,85 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
ASENSUS SURGICAL | 0,244 | +9,31 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
ORGANON | 17,100 | -2,20 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 19.04.2024 | The following instruments on XETRA do have their last trading day on 19.04.2024.Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 19.04.2024.ISIN NameUS2310211063 Cummins Inc.US68622V1061 Organon... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,318 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve changes auditor to MS Partners | ||
REWALK ROBOTICS | 4,675 | 0,00 % | ReWalk Robotics Ltd. - 8-K, Current Report | ||
JD HEALTH | 2,920 | -1,35 % | Aktie von JD Health heute am Aktienmarkt gefragt (2,82 €) | Im Plus liegt zur Stunde das Wertpapier von JD Health . Die Aktie notiert derzeit bei 2,82 Euro. Ein Kursplus von 4,44 Prozent steht gegenwärtig für die JD Health-Aktie zu Buche. Das Wertpapier verteuerte... ► Artikel lesen | |
EKSO BIONICS | 1,055 | -6,22 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 | ||
BIOCEPT | 6,800 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 02.11.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.11.2023ISIN NameCA91834N1006 VSBLTY... ► Artikel lesen | |
IMUNON | 1,250 | +2,46 % | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen |